Data / Form D filings / Singulex, Inc.
Singulex, Inc.: Form D filings
Singulex, Inc., a biotechnology company in Alameda, CA, filed 4 Form D notices with the SEC between 2011 and 2013. The latest, on June 7, 2013, reports $12.2 million sold of a $20.1 million offering to 6 investors.
Find out what Singulex, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1701 HARBOR BAY PARKWAY, SUITE 200, Alameda, CA, 94502
- Phone
- (510) 995-9000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1323620
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 7, 2013 | New notice | $20,076,681 | $12,189,449 | $7,887,232 | 6 | May 17, 2013 | sec.gov |
| Mar 15, 2012 | New notice | $21,297,899 | $15,335,540 | $5,962,359 | 8 | Feb 17, 2012 | sec.gov |
| Aug 5, 2011 | Amendment | $10,050,502 | $9,651,335 | $399,167 | 8 | May 6, 2011 | sec.gov |
| May 23, 2011 | New notice | $10,050,000 | $7,475,513 | $2,574,487 | 3 | May 6, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Heiner J. Dreismann | Director | |
| Philippe J. Goix | Director | |
| Gregory R. Johnson | Director | |
| Carl L. Gordon | Director | |
| Stephen L. Rose | Director | |
| Michael K. Bell | Executive Officer | |
| Andre R. Marion | Director | |
| Guido L. Baechler | Executive Officer, Director | |
| Fred K. Vogt | Director | |
| R. Douglas K. Norby | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jun 3, 2013 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Singulex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.